List of works - Paolo Catarsi

Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells

scientific article published on 5 May 2015

Angiotensin-converting enzyme (ACE) haplotypes and cyclosporine A (CsA) response: a model of the complex relationship between ACE quantitative trait locus and pathological phenotypes

scientific article published on 07 July 2005

Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

scientific article

Arachidonic acid-evoked Ca2+ signals promote nitric oxide release and proliferation in human endothelial colony forming cells

scientific article published on 12 September 2016

Conjugated polymers optically regulate the fate of endothelial colony-forming cells

scientific article published on 27 September 2019

Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity

scientific article published on 01 August 2019

Cyclosporin and organ specific toxicity: clinical aspects, pharmacogenetics and perspectives

scientific article

Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study

scientific article published on September 2004

Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis

scientific article

Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms

scientific article published on 12 March 2014

Impact of erythropoietin on the effects of irradiation under hypoxia.

scientific article

Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.

scientific article

Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis

scientific article published on 12 February 2013

JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis

scientific article

JAK2 exon 14 skipping in patients with primary myelofibrosis: a minor splice variant modulated by the JAK2-V617F allele burden

scientific article published on 24 January 2015

JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.

scientific article published on 29 February 2016

Kinetic and Angiogenic Activity of Circulating Endothelial Colony Forming Cells in Patients with Infantile Haemangioma Receiving Propranolol

scientific article published on 04 January 2019

No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis.

scientific article published on 28 May 2013

Polymorphisms in the osteopontin promoter affect its transcriptional activity.

scientific article

Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease.

scientific article published on 7 June 2017

Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis

scientific article published on 14 June 2020

Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis.

scientific article published on 16 August 2016

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation.

scientific article

The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells

scientific article

Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis

scientific article

List of works by Paolo Catarsi

Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells

Angiotensin-converting enzyme (ACE) haplotypes and cyclosporine A (CsA) response: a model of the complex relationship between ACE quantitative trait locus and pathological phenotypes

Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

Arachidonic acid-evoked Ca2+ signals promote nitric oxide release and proliferation in human endothelial colony forming cells

Conjugated polymers optically regulate the fate of endothelial colony-forming cells

Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity

Cyclosporin and organ specific toxicity: clinical aspects, pharmacogenetics and perspectives

Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study

Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis

Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms

Impact of erythropoietin on the effects of irradiation under hypoxia.

Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.

Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis

JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis

JAK2 exon 14 skipping in patients with primary myelofibrosis: a minor splice variant modulated by the JAK2-V617F allele burden

JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.

Kinetic and Angiogenic Activity of Circulating Endothelial Colony Forming Cells in Patients with Infantile Haemangioma Receiving Propranolol

No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis.

Polymorphisms in the osteopontin promoter affect its transcriptional activity.

Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease.

Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis

Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis.

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation.

The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells

Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis